Resultados de procura - Barry Antonacci

  • Mostrando 1 - 2 Resultados de 2
Limitar resultados
  1. 1
    In Vitro and In Vivo Activities of SCH 56592 (Posaconazole), a New Triazole Antifungal Agent, against <i>Aspergillus</i> and <i>Candida</i>

    In Vitro and In Vivo Activities of SCH 56592 (Posaconazole), a New Triazole Antifungal Agent, against <i>Aspergillus</i> and <i>Candida</i> por Anthony Cacciapuoti, David Loebenberg, Erik Corcoran, Fred Menzel, E. L. Moss, Christine Norris, Monika Michalski, Kimberly Raynor, Judith Halpern, Cara Mendrick, Brian M. Arnold, Barry Antonacci, Raulo Parmegiani, T. Yarosh-Tomaine, George H. Miller, R S Hare

    Publicado 2000
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Discovery of a Novel Class of Orally Active Antifungal β-1,3- <scp>d</scp> -Glucan Synthase Inhibitors

    Discovery of a Novel Class of Orally Active Antifungal β-1,3- <scp>d</scp> -Glucan Synthase Inhibitors por Scott S. Walker, Yiming Xu, Ilias Triantafyllou, Michelle F. Waldman, Cara Mendrick, Nathaniel H. Brown, Paul A. Mann, Andrew S. Chau, Reena Patel, Nicholas P. Bauman, Christine Norris, Barry Antonacci, Maya Gurnani, Anthony Cacciapuoti, Paul M. McNicholas, Samuel B. Wainhaus, R. Jason Herr, Rongze Kuang, Robert Aslanian, Pauline C. Ting, Todd A. Black

    Publicado 2011
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: